Tobacco use in surgical patients

Published on 07/02/2015 by admin

Filed under Anesthesiology

Last modified 07/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 930 times

Tobacco use in surgical patients

Yu Shi, MD, MPH and David O. Warner, MD

Approximately 20% of adults in the United States smoke cigarettes, and each year an estimated 10 million smokers undergo surgical procedures. Chronic and acute exposures to cigarette smoke cause profound changes in physiology that increase the perioperative risk of cardiovascular, pulmonary, and wound-related complications occurring (Figure 107-1). Thus, the knowledge of how smoking and abstinence from cigarettes affect perioperative physiology is of practical importance. This chapter will review (1) why smokers should maintain perioperative abstinence from smoking for as long as possible, (2) why surgery provides a good opportunity to quit smoking permanently, and (3) how anesthesiologists can help their patients quit smoking.

Smoking abstinence and perioperative outcomes

Although some of the effects of smoking are irreversible (e.g., airway damage in chronic obstructive pulmonary disease), abstinence from smoking can improve the function of many organ systems and reduce the risk of perioperative complications. The amount of time needed for the body to recover from the reversible effects of smoking varies widely. However, the effects of many smoke constituents are transient. For example, nicotine has a short half-life (∼1-2 h), so that plasma nicotine levels are very low after 8 to 12 h of abstinence.

Cardiovascular outcomes

Smoking is a major risk factor for cardiovascular diseases. In the long term, abstinence from smoking decreases the risk for all-cause death in smokers with coronary artery disease by approximately one third. Smoking a cigarette acutely increases myocardial O2 consumption by increasing heart rate, blood pressure, and myocardial contractility. These effects are likely mediated primarily by nicotine, which both increases sympathetic outflow and directly contracts some (but not all) peripheral vessels. The carbon monoxide in cigarette smoke binds to hemoglobin and shifts the oxyhemoglobin dissociation curve to the left, interfering with O2 release. These effects all contribute to an increased risk of myocardial ischemia. During anesthesia, the frequency of ischemia, as assessed by the electrocardiogram, is well correlated with exhaled carbon monoxide levels. This suggests that smoking in the immediate preoperative period increases acute cardiovascular risk and that even brief preoperative abstinence may benefit the heart because carbon monoxide values fall rapidly after abstinence from smoking (within about 12 h). As the effects of nicotine and carbon monoxide dissipate, the risks of acute ischemia may also quickly decrease as myocardial O2 demand decreases and O2 supply increases. After 12 h of abstinence, maximum exercise capacity, a measure of overall cardiovascular function, is significantly increased.

Respiratory outcomes

Buy Membership for Anesthesiology Category to continue reading. Learn more here